US › Healthcare

The Joint Corp (JYNT)

US · Healthcare · Medical Care Facilities

$6.85-7.06%

Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue

$13.6M

Revenue YoY

+1.3%

Net profit

$1.5M

Profit YoY

+70.3%

EPS

$0.10

EPS estimate

$0.11

Net margin

10.7%

EPS came in at 0.10 against a street estimate of 0.11 — a miss of 9.1%.

Key statistics

Market cap

$104.2M

P/E

52.6

Forward P/E

9.5

P/B

6.42

Book value

$1.16

EPS (TTM)

$0.14

52-week high

$10.67

52-week low

$6.63

50-day MA

$7.72

200-day MA

$8.55

Beta

1.16

Analyst view

Analysts rate The Joint Corp a buy (1 buy, 3 hold, 0 sell out of 4) with an average price target of $10.00.

Shareholding

Insiders

16.23%

Institutions

69.67%

Largest institutional holders

Fund	Stake
Bandera Partners LLC	27.84%
Skylands Capital, LLC	6.69%
JCP Investment Management, LLC	4.20%
Vanguard Capital Management, LLC	3.94%
Keller Group Invmt Management Inc	2.37%
BlackRock Inc	2.04%
Jane Street Group LLC	1.67%
Vanguard Portfolio Management, LLC	1.59%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for The Joint Corp — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.